Reviewed by Michael Gill, B. Sc.
20 Multiple System Atrophy Clinical Trials Near Me
Top Hospitals for Multiple System Atrophy Clinical Trials
Image of Autonomic Dysfunction Center/ Vanderbilt University Medical Center in Tennessee.
Autonomic Dysfunction Center/ Vanderbilt University Medical Center
Nashville
6Active Trials
5All Time Trials for Multiple System Atrophy
2016First Multiple System Atrophy Trial
Image of Vanderbilt University Medical Center in Tennessee.
Vanderbilt University Medical Center
Nashville
4Active Trials
8All Time Trials for Multiple System Atrophy
2008First Multiple System Atrophy Trial
Top Cities for Multiple System Atrophy Clinical Trials
Image of Chicago in Illinois.
Chicago
5Active Trials
Rush University Medical CenterTop Active Site
Most Recent Multiple System Atrophy Clinical Trials
Top Treatments for Multiple System Atrophy Clinical Trials
Treatment Name
Active Multiple System Atrophy Clinical Trials
All Time Trials for Multiple System Atrophy
First Recorded Multiple System Atrophy Trial
Abdominal compression
2
2
2015
Delayed Start - PD
1
1
2022
Main Cohort: TAK-341 Dose 2
1
1
2022
Active CPAP
1
1
2022
[18F]UCB-2897
1
1
2022
Recently Completed Studies with FDA Approved Treatments for Multiple System Atrophy
Treatment
Year
Sponsor
[F-18]PBR06
2020
Brigham and Women's Hospital
Verdiperstat
2019
Biohaven Pharmaceuticals, Inc.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 21st, 2021

Last Reviewed: November 24th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Camilleri ET, Gustafson MP, Dudakovic A, Riester SM, Garces CG, Paradise CR, Takai H, Karperien M, Cool S, Sampen HJ, Larson AN, Qu W, Smith J, Dietz AB, van Wijnen AJ. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016 Aug 11;7(1):107. doi: 10.1186/s13287-016-0370-8. https://pubmed.ncbi.nlm.nih.gov/275153082 Cella D, Lai JS, Nowinski CJ, Victorson D, Peterman A, Miller D, Bethoux F, Heinemann A, Rubin S, Cavazos JE, Reder AT, Sufit R, Simuni T, Holmes GL, Siderowf A, Wojna V, Bode R, McKinney N, Podrabsky T, Wortman K, Choi S, Gershon R, Rothrock N, Moy C. Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology. 2012 Jun 5;78(23):1860-7. doi: 10.1212/WNL.0b013e318258f744. Epub 2012 May 9. https://pubmed.ncbi.nlm.nih.gov/225736263 Okamoto LE, Celedonio JE, Smith EC, Gamboa A, Shibao CA, Diedrich A, Paranjape SY, Black BK, Muldowney JAS 3rd, Peltier AC, Habermann R, Crandall CG, Biaggioni I. Local Passive Heat for the Treatment of Hypertension in Autonomic Failure. J Am Heart Assoc. 2021 Apr 6;10(7):e018979. doi: 10.1161/JAHA.120.018979. Epub 2021 Mar 19. https://pubmed.ncbi.nlm.nih.gov/337391234 Weiss JN, Levy S. Neurologic Stem Cell Treatment Study (NEST) using bone marrow derived stem cells for the treatment of neurological disorders and injuries: study protocol for a nonrandomized efficacy trial. Clin Trials Degener Dis. 2016 [cited 2019 Jun 18];1:176-80. 5 Chapman CD, Frey WH 2nd, Craft S, Danielyan L, Hallschmid M, Schiöth HB, Benedict C. Intranasal treatment of central nervous system dysfunction in humans. Pharm Res. 2013 Oct;30(10):2475-84. doi: 10.1007/s11095-012-0915-1. Epub 2012 Nov 8. Review. https://pubmed.ncbi.nlm.nih.gov/231358226 Cella D, Nowinski C, Peterman A, Victorson D, Miller D, Lai JS, Moy C. The neurology quality-of-life measurement initiative. Arch Phys Med Rehabil. 2011 Oct;92(10 Suppl):S28-36. doi: 10.1016/j.apmr.2011.01.025. https://pubmed.ncbi.nlm.nih.gov/219589207 Lescaudron L, Naveilhan P, Neveu I. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases. Curr Med Chem. 2012;19(35):6018-35. Review. https://pubmed.ncbi.nlm.nih.gov/229635678 Jiang Y, Zhu J, Xu G, Liu X. Intranasal delivery of stem cells to the brain. Expert Opin Drug Deliv. 2011 May;8(5):623-32. doi: 10.1517/17425247.2011.566267. Epub 2011 Mar 19. Review. https://pubmed.ncbi.nlm.nih.gov/214177829 Bhasin A, Srivastava M, Bhatia R, Mohanty S, Kumaran S, Bose S. Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. J Stem Cells Regen Med. 2012 Nov 26;8(3):181-9. eCollection 2012. https://pubmed.ncbi.nlm.nih.gov/2469319610 Laroni A, de Rosbo NK, Uccelli A. Mesenchymal stem cells for the treatment of neurological diseases: Immunoregulation beyond neuroprotection. Immunol Lett. 2015 Dec;168(2):183-90. doi: 10.1016/j.imlet.2015.08.007. Epub 2015 Aug 18. Review. https://pubmed.ncbi.nlm.nih.gov/26296458